These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

539 related items for PubMed ID: 31993782

  • 21. Long-term renal survival and undetected risk factors of IgA nephropathy in Chinese children-a retrospective 1243 cases analysis from single centre experience.
    Wu H, Fang X, Xia Z, Gao C, Peng Y, Li X, Zhang P, Kuang Q, Wang R, Wang M.
    J Nephrol; 2020 Dec; 33(6):1263-1273. PubMed ID: 32507961
    [Abstract] [Full Text] [Related]

  • 22. Long-term outcome of childhood IgA nephropathy with minimal proteinuria.
    Higa A, Shima Y, Hama T, Sato M, Mukaiyama H, Togawa H, Tanaka R, Nozu K, Sako M, Iijima K, Nakanishi K, Yoshikawa N.
    Pediatr Nephrol; 2015 Dec; 30(12):2121-7. PubMed ID: 26238276
    [Abstract] [Full Text] [Related]

  • 23. Are children with IgA nephropathy different from adult patients?
    Su B, Jiang Y, Li Z, Zhou J, Rong L, Feng S, Zhong F, Sun S, Zhang D, Xia Z, Feng C, Huang W, Li X, Chen C, Hao Z, Wang M, Qin L, Chen M, Li Y, Ding J, Bao Y, Liu X, Deng F, Cheng X, Zhang L, Zhang X, Yang H, Peng X, Sun Q, Deng L, Jiang X, Xie M, Gao Y, Yu L, Liu L, Gao C, Mao J, Zheng W, Dang X, Xia H, Wang Y, Zhong X, Ding J, Lv J, Zhang H.
    Pediatr Nephrol; 2024 Aug; 39(8):2403-2412. PubMed ID: 38578470
    [Abstract] [Full Text] [Related]

  • 24. Steroid therapy in children with IgA nephropathy.
    Cambier A, Boyer O, Deschenes G, Gleeson J, Couderc A, Hogan J, Robert T.
    Pediatr Nephrol; 2020 Mar; 35(3):359-366. PubMed ID: 30778826
    [Abstract] [Full Text] [Related]

  • 25. Validity of the Oxford classification of IgA nephropathy in children.
    Shima Y, Nakanishi K, Hama T, Mukaiyama H, Togawa H, Hashimura Y, Kaito H, Sako M, Iijima K, Yoshikawa N.
    Pediatr Nephrol; 2012 May; 27(5):783-92. PubMed ID: 22134880
    [Abstract] [Full Text] [Related]

  • 26. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
    Tian S, Yang X, Luo J, Guo H.
    Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
    [Abstract] [Full Text] [Related]

  • 27. Renal biopsy findings and clinical indicators of patients with hematuria without overt proteinuria.
    Hoshino Y, Kaga T, Abe Y, Endo M, Wakai S, Tsuchiya K, Nitta K.
    Clin Exp Nephrol; 2015 Oct; 19(5):918-24. PubMed ID: 25672293
    [Abstract] [Full Text] [Related]

  • 28. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease.
    Li XW, Liang SS, Le WB, Cheng SQ, Zeng CH, Wang JQ, Liu ZH.
    J Nephrol; 2016 Aug; 29(4):567-73. PubMed ID: 26537358
    [Abstract] [Full Text] [Related]

  • 29. Clinical outcomes of IgA nephropathy patients with different proportions of crescents.
    Zhang W, Zhou Q, Hong L, Chen W, Yang S, Yang Q, Chen W, Yu X.
    Medicine (Baltimore); 2017 Mar; 96(11):e6190. PubMed ID: 28296731
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Long-term results of a randomized controlled trial in childhood IgA nephropathy.
    Kamei K, Nakanishi K, Ito S, Saito M, Sako M, Ishikura K, Hataya H, Honda M, Iijima K, Yoshikawa N, Japanese Pediatric IgA Nephropathy Treatment Study Group.
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1301-7. PubMed ID: 21493743
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C, Rizza V, Casellato D, Stivali G, Rachele G, Napodano P, Olivieri G, Gallieni M, D'Amico G.
    J Nephrol; 2012 Jun; 25(5):810-8. PubMed ID: 22252844
    [Abstract] [Full Text] [Related]

  • 37. Prognostic role of glomerular electron microscopy lesions in IgA nephropathy: "the devil is in the details".
    Terinte-Balcan G, Stancu S, Zugravu A, Capusa C, Radu A, Mircescu G, Stefan G.
    J Nephrol; 2023 Nov; 36(8):2233-2243. PubMed ID: 37632668
    [Abstract] [Full Text] [Related]

  • 38. Severity of nephrotic IgA nephropathy according to the Oxford classification.
    Moriyama T, Nakayama K, Iwasaki C, Ochi A, Tsuruta Y, Itabashi M, Tsukada M, Takei T, Uchida K, Nitta K.
    Int Urol Nephrol; 2012 Aug; 44(4):1177-84. PubMed ID: 22231129
    [Abstract] [Full Text] [Related]

  • 39. Clinicopathological significance of glomerular capillary IgA deposition in childhood IgA nephropathy.
    Shima Y, Nakanishi K, Mukaiyama H, Tanaka Y, Wada T, Tanaka R, Kaito H, Nozu K, Sako M, Iijima K, Yoshikawa N.
    Pediatr Nephrol; 2021 Apr; 36(4):899-908. PubMed ID: 33011820
    [Abstract] [Full Text] [Related]

  • 40. Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients.
    Fabiano RC, Pinheiro SV, de Almeida Araújo S, Simões E Silva AC.
    Nephrology (Carlton); 2016 Dec; 21(12):995-1002. PubMed ID: 27414046
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.